AWARD OUTCOME
What happened
London Borough of Camden published a Provider Selection Regime (PSR) intention-to-award notice for a peer-led drug harm reduction service for adult Camden residents. THE HEPATITIS C TRUST is the named, verified supplier. However, the source also says the contract had not yet formally been awarded, while structured award and contract records are marked active and include a signed-date field.
Published outcomeNamed supplier: THE HEPATITIS C TRUST (company number 05069924), linked to lot 1. The published total contract value is £150,000, but the record contains unresolved lifecycle contradictions.
Market significanceA £150,000 proposed 12-month community harm-reduction service, covering peer-led engagement, safer injecting equipment, naloxone and referral/signposting support for vulnerable adult Camden residents.
AWARDED SUPPLIERS AND LOTS
1 supplier record analysed
THE HEPATITIS C TRUST
94% confidenceAward 096428-2026-1 · Lots 1 · £150,000 total published contract value; not individually allocated beyond this sole named supplier record GBP · Named supplier in an intention-to-award notice; structured award record active
View supporting evidence
The award names The Hepatitis C Trust for lot 1. Supplier verification confirms company number 05069924 and verified legal name THE HEPATITIS C TRUST. The contract record states £150,000.
LIFECYCLE
Award or contract stage
Published notice type
98% confidenceAward, contract notice
View supporting evidence
Release history records notice 096428-2026 dated 13 October 2026 with tags "award" and "contract".
Notice character
99% confidenceIntention to award under PSR
View supporting evidence
Procurement rationale states: "This is a Provider Selection Regime (PSR) intention to award notice" and "This contract has not yet formally been awarded".
Lot status
99% confidenceCancelled
View supporting evidence
Tender lot 1 is marked "cancelled".
Structured award and contract status
98% confidenceActive
View supporting evidence
Award 096428-2026-1 and contract 096428-2026-1 are each marked "active" in the supplied structured data.
Contract signature field
95% confidence12 October 2026
View supporting evidence
Contract 096428-2026-1 contains dateSigned: 2026-10-12T00:00:00+01:00.
VALUES
Published values explained
Published total contract value
98% confidence£150,000
View supporting evidence
Lot description states a total value of £150,000; contract 096428-2026-1 records amount 150000 GBP.
Value basis
85% confidenceTotal value; pricing breakdown not supplied
View supporting evidence
The lot narrative calls this a "total value" of £150,000. No pricing schedule or value basis is supplied.
TIMELINE
Procurement timeline
Initial notice publication
98% confidence25 August 2026
View supporting evidence
Release history records planning/tender release 081030-2026 on 25 August 2026.
Award/contract notice publication
98% confidence13 October 2026
View supporting evidence
Process source_updated_at and release history give 13 October 2026 for release 096428-2026.
Representations deadline
98% confidence23 October 2026
View supporting evidence
Procurement rationale states that representations must be made to decision makers by 23 October 2026.
Stated service commencement
92% confidence1 November 2026
View supporting evidence
Lot description states that the service will commence on 1 November 2026.
Stated duration
92% confidence12 months
View supporting evidence
Lot description states the service will commence for 12 months.
SCOPE
What was awarded
Service
98% confidenceCommunity-based, peer-led drug harm reduction service
View supporting evidence
Tender description describes low-threshold peer-led engagement, harm-reduction support and advice.
Core activities
98% confidenceNeedles and safer injecting equipment; naloxone training and provision; safer drug-use information; brief interventions; blood-borne virus prevention information; signposting
View supporting evidence
These activities are listed in the tender description.
Target population
98% confidenceAdult Camden residents, primarily people experiencing homelessness, residents of hostels or supported accommodation, people outside structured treatment, and women facing multiple disadvantage
View supporting evidence
Tender description specifies these groups.
Delivery geography
92% confidenceUKI31 (Inner London – West), with Camden as the buyer and intended resident population
View supporting evidence
Delivery address region is UKI31; the description refers to adult Camden residents.
Classification
99% confidenceCPV 85100000 — Health services
View supporting evidence
Tender classification and item additional classification state CPV 85100000.
PROCEDURE
Procedure and competition
Procedure
99% confidenceLimited procedure / award without prior publication of a call for competition
View supporting evidence
Process procurement method is "limited" and procurement method details state "Award procedure without prior publication of a call for competition".
Regime
99% confidenceHealth Care Services (Provider Selection Regime) Regulations 2023
View supporting evidence
Procurement rationale explicitly identifies the PSR regulations and says the Public Contracts Regulations 2015 do not apply.
Selection approach
98% confidenceMost Suitable Provider process
View supporting evidence
Lot description states that Camden applied the Most Suitable Provider process under the PSR.
Published criteria
86% confidenceQuality criterion: most suitable provider process (description 100); cost criterion: Value (description 20)
View supporting evidence
Lot awardCriteria lists these quality and cost criteria. The source does not explain the scoring scale or weighting interpretation.
Competition information
99% confidenceNot supplied
View supporting evidence
No bidder count, competing suppliers, evaluation scores or detailed award assessment is provided.
CONTRACT TERMS
Published contract terms
Stated term
92% confidence12 months from 1 November 2026
View supporting evidence
Lot description states that the service will commence on 1 November 2026 for 12 months.
Options
98% confidenceNo options
View supporting evidence
Tender lot 1 hasOptions is false.
Extension or renewal terms
99% confidenceNot supplied
View supporting evidence
No extension or renewal provisions are present in the supplied data.
COMMERCIAL VIEW
Commercial observations
Market route
98% confidenceDirect PSR Most Suitable Provider route rather than an openly competed call
View supporting evidence
The notice describes the Most Suitable Provider process and an award without prior publication of a call for competition.
Buyer rationale
94% confidenceCamden cites specialist peer-led expertise and track record, local needs, value for money, health outcomes, and reduction of drug-related harm and inequalities
View supporting evidence
These reasons are stated in the lot description. They are buyer assertions, not published comparative evaluation results.
Market entry signal
85% confidenceThe notice describes this as a new service and says the named provider is new to Camden
View supporting evidence
Lot description states: "This is a new Service and Hepatitus C is a new provider for Camden."
DATA QUALITY
Gaps and source limitations
Lifecycle contradiction
99% confidenceThe notice says the contract had not yet formally been awarded, but the structured award and contract are active and the contract includes a 12 October 2026 signed-date field.
View supporting evidence
Procurement rationale, award status, contract status and contract dateSigned conflict. This analysis does not resolve the conflict or treat the contract as conclusively awarded or active.
Lot status inconsistency
99% confidenceLot 1 is marked cancelled despite an active award and contract record linked to it.
View supporting evidence
Tender lot 1 status is cancelled; award and contract 096428-2026-1 are active and relate to lot 1.
Dates require caution
94% confidenceThe stated 1 November 2026 start follows a 23 October 2026 representations deadline, but the source does not provide a final award confirmation.
View supporting evidence
The lot narrative gives both dates and identifies the notice as an intention to award.
Information not supplied in the published notice
99% confidenceNo final award date, contract end date, bid count, scoring results, pricing breakdown, individual lot value, or detailed evaluation record is supplied.
View supporting evidence
These fields are absent or null in the supplied data.
SOURCE DATA LIMITATIONS
Information not supplied in the published notice
- The source contains unresolved lifecycle contradictions: it calls the publication an intention to award and says no formal award had occurred, while linked structured award and contract records are active and include a signed-date field.
- Lot 1 is marked cancelled while the linked award and contract records are active; the supplied evidence does not establish which status reflects the final position.
- The £150,000 figure is published as a total value, but no pricing breakdown or explicit value basis is supplied.
- Information not supplied in the published notice includes a final award date, contract end date, extension or renewal terms, bid count, competing suppliers, evaluation scores and detailed pricing.
- The stated 12-month duration and 1 November 2026 commencement are notice statements, not evidence that delivery commenced.
MARKET THEMES
Relevant award themes
London Borough of CamdenTHE HEPATITIS C TRUSTpeer-led drug harm reductionProvider Selection RegimePSR intention to awardCamden health servicesnaloxonehealth services
COMMON QUESTIONS
About this award
Who is the named supplier for Camden's Peer-Led Drug Harm Reduction Programme?
THE HEPATITIS C TRUST, verified against company number 05069924, is the named supplier for lot 1.
What is the published value?
The published total contract value is £150,000.
Has the contract been conclusively awarded?
Not conclusively from the supplied evidence. The notice says it is an intention to award and that the contract had not yet formally been awarded, although structured records also show an active award and contract with a signed-date field.
What services are proposed?
The service includes peer-led harm-reduction engagement, safer injecting equipment, naloxone provision and training, safer drug-use information, blood-borne virus prevention information, and signposting.
ProcuraAxis award analysis supplements, but does not replace, the official award notice, contract data or procurement documents. “Awarded” does not by itself prove that a contract has been signed.